Jana Hercogová

4.7k total citations
158 papers, 3.0k citations indexed

About

Jana Hercogová is a scholar working on Dermatology, Immunology and Epidemiology. According to data from OpenAlex, Jana Hercogová has authored 158 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Dermatology, 50 papers in Immunology and 32 papers in Epidemiology. Recurrent topics in Jana Hercogová's work include Dermatology and Skin Diseases (31 papers), Psoriasis: Treatment and Pathogenesis (29 papers) and melanin and skin pigmentation (16 papers). Jana Hercogová is often cited by papers focused on Dermatology and Skin Diseases (31 papers), Psoriasis: Treatment and Pathogenesis (29 papers) and melanin and skin pigmentation (16 papers). Jana Hercogová collaborates with scholars based in Czechia, Italy and Germany. Jana Hercogová's co-authors include Torello Lotti, Hans Christian Wulf, Daniel H. Christensen, O. Faurskov Nielsen, Monika Gniadecka, Daniela Vaňousová, Ilaria Ghersetich, Benedetta Brazzini, Lumír Pock and Filip Rob and has published in prestigious journals such as PLoS ONE, Journal of Clinical Microbiology and Annals of the Rheumatic Diseases.

In The Last Decade

Jana Hercogová

154 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jana Hercogová Czechia 29 1.1k 647 555 436 417 158 3.0k
Vera Mahler Germany 34 2.9k 2.6× 426 0.7× 656 1.2× 461 1.1× 90 0.2× 232 5.0k
Ulrich R. Hengge Germany 42 946 0.9× 858 1.3× 1.1k 2.0× 1.9k 4.4× 355 0.9× 164 6.0k
Ellen M. Zimmermann United States 35 284 0.3× 395 0.6× 1.1k 2.0× 703 1.6× 147 0.4× 108 4.3k
J.Q. Del Rosso United States 38 4.3k 3.9× 584 0.9× 1.7k 3.0× 423 1.0× 1.1k 2.6× 590 6.3k
Xu Chen China 33 190 0.2× 431 0.7× 563 1.0× 1.6k 3.6× 245 0.6× 215 3.8k
B. Weeke Denmark 41 1.4k 1.3× 615 1.0× 408 0.7× 920 2.1× 148 0.4× 199 6.3k
Peter Hill United Kingdom 34 1.4k 1.2× 219 0.3× 597 1.1× 555 1.3× 192 0.5× 150 4.3k
Andrew J. Mitchell Australia 32 136 0.1× 1.4k 2.1× 295 0.5× 1.5k 3.5× 87 0.2× 76 4.0k
Maria Notomi Sato Brazil 38 669 0.6× 1.2k 1.9× 549 1.0× 1.2k 2.8× 230 0.6× 255 5.2k
Thomas Werfel Germany 33 2.6k 2.3× 727 1.1× 260 0.5× 286 0.7× 72 0.2× 187 5.4k

Countries citing papers authored by Jana Hercogová

Since Specialization
Citations

This map shows the geographic impact of Jana Hercogová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jana Hercogová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jana Hercogová more than expected).

Fields of papers citing papers by Jana Hercogová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jana Hercogová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jana Hercogová. The network helps show where Jana Hercogová may publish in the future.

Co-authorship network of co-authors of Jana Hercogová

This figure shows the co-authorship network connecting the top 25 collaborators of Jana Hercogová. A scholar is included among the top collaborators of Jana Hercogová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jana Hercogová. Jana Hercogová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Coufal, Štěpán, Miloslav Kverka, Jakub Kreisinger, et al.. (2023). Serum TGF-β1 and CD14 Predicts Response to Anti-TNF-α Therapy in IBD. Journal of Immunology Research. 2023. 1–16. 3 indexed citations
3.
Němcová, Jana, Jan Riegert, Filip Rob, et al.. (2022). Prevalence of oral and anal human papillomavirus infection in Czech predominantly HIV-positive men having sex with men - data from a previously unreported population. International Journal of STD & AIDS. 33(12). 1054–1064. 8 indexed citations
4.
5.
Roubalová, Radka, Martin Kolář, Zuzana Stehlíková, et al.. (2021). Fecal Microbiome Changes and Specific Anti-Bacterial Response in Patients with IBD during Anti-TNF Therapy. Cells. 10(11). 3188–3188. 21 indexed citations
6.
Stehlíková, Zuzana, Klara Kostovcikova, Miloslav Kverka, et al.. (2019). Crucial Role of Microbiota in Experimental Psoriasis Revealed by a Gnotobiotic Mouse Model. Frontiers in Microbiology. 10. 236–236. 48 indexed citations
7.
França, Katlein, et al.. (2018). Primavera: A new therapeutical approach to vulvo-vaginal atrophy. Dermatologic Therapy. 31(6). e12678–e12678. 4 indexed citations
8.
Hercogová, Jana, Massimo Fioranelli, Serena Gianfaldoni, et al.. (2018). Investigation of the efficacy of Dr Michaels® (Soratinex®) family in maintaining a symptom-free state for patients with psoriasis in remission. A retrospective, comparative study.. PubMed. 30(2 Suppl 3). 73–5. 2 indexed citations
9.
França, Katlein, Jana Hercogová, Massimo Fioranelli, et al.. (2018). A European prospective, randomized placebo-controlled doubleblind Study on the efficacy and safety of Dr Michaels® (also branded as Soratinex®) product family for stable chronic plaque psoriasis.. PubMed. 30(2 Suppl 3). 9–14. 2 indexed citations
10.
Rob, Filip, et al.. (2018). First reported case of chancroid in the Czech Republic. International Journal of STD & AIDS. 29(11). 1127–1129. 2 indexed citations
11.
Gianfaldoni, Serena, Jana Hercogová, Massimo Fioranelli, et al.. (2018). An innovative, promising topical treatment for psoriasis: a Romanian clinical study.. PubMed. 30(2 Suppl 3). 109–13. 2 indexed citations
12.
França, Katlein, Michael Tirant, Jana Hercogová, et al.. (2018). Quality of life aspects of patients with psoriasis using a series of herbal products.. PubMed. 30(2 Suppl 3). 121–7. 2 indexed citations
13.
Jůzlová, Kateřina, et al.. (2017). The first case of lymphogranuloma venereum in a woman in East-Central Europe and its multiple co-infections. Folia Microbiologica. 63(1). 93–95. 1 indexed citations
14.
Rob, Filip, Ruth Tachezy, Petr Škapa, et al.. (2017). Concordance of HPV‐DNA in cervical dysplasia or genital warts in women and their monogamous long‐term male partners. Journal of Medical Virology. 89(9). 1662–1670. 5 indexed citations
15.
Votrubová, Jana, et al.. (2016). Cardiovascular Comorbidities in Patients with Psoriasis: Risk Profile Including Carotide Ultrasonography Assessed in Hospital-based Case Control Study.. PubMed. 24(3). 187–92. 2 indexed citations
17.
Chernyshov, Pavel V., et al.. (2015). An International Multi-center Study on Self-assessed and Family Quality of Life in Children with Atopic Dermatitis.. PubMed. 23(4). 247–53. 35 indexed citations
18.
Holı́ková, Zuzana, Daniela Massi, Torello Lotti, & Jana Hercogová. (2004). Insight into the pathogenesis of sporadic basal cell carcinoma. International Journal of Dermatology. 43(12). 865–869. 20 indexed citations
19.
Gniadecka, Monika, Peter A. Philipsen, Sonja Wessel, et al.. (2004). Melanoma Diagnosis by Raman Spectroscopy and Neural Networks: Structure Alterations in Proteins and Lipids in Intact Cancer Tissue. Journal of Investigative Dermatology. 122(2). 443–449. 271 indexed citations
20.
Hercogová, Jana, et al.. (2003). Narrow‐band UV‐B micro‐phototherapy: a new treatment for vitiligo. Journal of the European Academy of Dermatology and Venereology. 17(2). 171–177. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026